Personalis, Inc. (PSNL)
9.04
-0.02
(-0.22%)
USD |
NASDAQ |
Mar 02, 16:00
9.04
0.00 (0.00%)
After-Hours: 20:00
Personalis Research and Development Expense (Annual) : 50.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 379.09M |
| Hologic, Inc. | 248.20M |
| Pacific Biosciences of California, Inc. | 95.21M |
| Twist Bioscience Corp. | 80.28M |
| Ionis Pharmaceuticals, Inc. | 913.18M |